LINC02207

Across TCGA pan-cancer cohorts, LINC02207 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC02207 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC02207 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02207 expression acts as an unfavorable survival marker, although some lineages such as BRCA and HNSC show a favorable association.

BRCA, HNSC, and MESO are the cancer types where LINC02207 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.960	0.923	.001	77	view →
HNSC	DFS	Quartile	IV	0.776	0.549	<.001	60	view →
MESO	DFS	Tertile	All	0.510	0.250	<.001	54	view →
UCS	OS	Median	All	0.490	0.199	.007	48	view →
CESC	OS	Quartile	All	0.930	0.739	<.001	48	view →
LGG	DFS	Tertile	All	0.312	0.536	<.001	41	view →
OV	OS	Tertile	II,III,IV	0.632	0.741	.008	34	view →
UVM	DFS	Quartile	II,III,IV	0.309	0.736	.008	27	view →
ACC	DFS	Median	II,III,IV	0.151	0.614	.010	22	view →
COAD	OS	Tertile	IV	0.910	0.361	.005	18	view →
SKCM	OS	Tertile	All	0.403	0.277	.009	16	view →
UCEC	OS	Median	All	0.619	0.712	.009	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC02207–BRCA (DFS)

Open the BRCA breakdown →